The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib INEOV neoadjuvant trial of durvalumab +/- tremelimumab with platinum chemotherapy for patients (pts) with unresectable ovarian cancer (OC): Final complete resection and pathological response rates.
 
Alexandra Leary
Honoraria - Medscape
Consulting or Advisory Role - AstraZeneca (Inst); Blueprint Medicines (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Merck Serono (Inst); MSD (Inst); PEGASCY; Tesaro (Inst); zentalis
Research Funding - Inivata (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Tesaro
 
Thibault De La Motte Rouge
Honoraria - AstraZeneca; Mylan; Pfizer; Roche/Genentech; Tesaro
Consulting or Advisory Role - AstraZeneca; Eisai; GlaxoSmithKline; MSD Oncology (Inst); Mylan; Pfizer; Roche; Tesaro
Research Funding - AstraZeneca (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Alain Lortholary
Honoraria - AstraZeneca; clovis oncology; Roche; Tesaro/GSK; Tesaro/GSK
 
Bernard Asselain
Honoraria - AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Pierre Fabre; Roche; SERVIER
 
Jerome Alexandre
Honoraria - AstraZeneca; Clovis Oncology; Eisai Europe; GlaxoSmithKline; MSD Oncology; MSD Oncology; Novartis; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Eisaï; GlaxoSmithKline; MSD Oncology
Research Funding - Janssen (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Janssen; Novartis
 
Anne Floquet
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; MSD; PharmaMar
Other Relationship - AstraZeneca; GlaxoSmithKline; MSD
 
Aude Marie Savoye
No Relationships to Disclose
 
Nicolas Delanoy
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD Oncology
Consulting or Advisory Role - Clovis Oncology; GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline; Sanofi
 
Céline Gavoille
No Relationships to Disclose
 
Benoit You
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Clovis Oncology; Daiichi Sankyo Europe GmbH; ECS PROGASTRIN; GlaxoSmithKline; Immunomedics; LEK; MSD Oncology; Myriad Genetics; Novartis; Roche/Genentech; Seagen; TESARO
Research Funding - Clovis Oncology (Inst); Merck Serono (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BMS; MSD Oncology; Roche/Genentech
 
Veronique D'hondt
No Relationships to Disclose
 
Julien Grenier
Travel, Accommodations, Expenses - AstraZeneca; Eisai Europe
 
Catherine Genestie
No Relationships to Disclose
 
Laure Chardin
Research Funding - AstraZeneca
 
Eric Pujade-Lauraine
Employment - Arcagy-Gineco
Honoraria - AstraZeneca; GlaxoSmithKline
Consulting or Advisory Role - AstraZeneca; Incyte; Merck; Roche
Research Funding - AstraZeneca (Inst)
Other Relationship - Arcagy-Gineco